🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Radiotherapy can activate local and systemic immune responses through a var...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04
Trial ID
NCT06914050
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308
Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...
Status
Completed
Location
Hunan cancer hospital
Start Date
2020-06-01
Trial ID
NCT04636762
Treatments Being Tested
This is a 6 week crossover study in current and former smokers with and wit...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2024-03-27
Trial ID
NCT05567562
Treatments Being Tested
TNBC is a heterogeneous disease with distinct pathological, genetic, and cl...
Status
Not Yet Recruiting
Location
SLK-Kliniken Heilbronn GmbH, Klinik für Gynäkologie und Geburtshilfe
Start Date
2026-08-30
Trial ID
NCT07178730
This phase II trial compares the effect of usual treatment of docetaxel che...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-03-03
Trial ID
NCT05408845
The goal of this clinical trial is to investigate the efficacy, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06620796
Treatments Being Tested
This study is a prospective, open-label, multicenter, randomized controlled...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-15
Trial ID
NCT07005557
Treatments Being Tested
This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Status
Unknown
Location
Cancer institute
Start Date
2016-12
Trial ID
NCT03123770
Treatments Being Tested